ERP Trademark

Trademark Overview


On Friday, December 7, 2018, a trademark application was filed for ERP with the United States Patent and Trademark Office. The USPTO has given the ERP trademark a serial number of 88221611. The federal status of this trademark filing is REGISTERED as of Tuesday, August 25, 2020. This trademark is owned by Mononuclear Therapeutics Limited. The ERP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for medical purposes for blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; plasma for treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; diagnostic and therapeutic preparations for medical or veterinary use, in particular preparations produced using molecular biological, biotechnological and genetic methods; surgical implants grown from stem cells; stem cells for medical purposes; pharmaceutical preparations for stem cell transplantation, therapy and research;...
erp

General Information


Serial Number88221611
Word MarkERP
Filing DateFriday, December 7, 2018
Status700 - REGISTERED
Status DateTuesday, August 25, 2020
Registration Number6137043
Registration DateTuesday, August 25, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for medical purposes for blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; plasma for treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; diagnostic and therapeutic preparations for medical or veterinary use, in particular preparations produced using molecular biological, biotechnological and genetic methods; surgical implants grown from stem cells; stem cells for medical purposes; pharmaceutical preparations for stem cell transplantation, therapy and research; pharmaceutical and veterinary preparations for treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; sanitary preparations for medical purposes; blood plasma; reagents for medical purposes; medical diagnostic reagent; biological preparations for medical purposes used in the treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; chemical preparations for pharmaceutical purposes, namely, chemical preparations for blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders; diagnostic preparations for medical purposes; pharmaceutical products for the treatment of blood system disorders, cardiac disorders, connective tissue disorders, endocrine disorders, immune system disorders, metabolism and nutrition disorders, neoplasms, nervous system disorders, pregnancy, puerperium and perinatal disorders, skin and subcutaneous tissue disorders, vascular disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 31, 2018
Primary Code005
First Use Anywhere DateFriday, November 1, 2019
First Use In Commerce DateFriday, November 1, 2019

Trademark Owner History


Party NameMononuclear Therapeutics Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressShatin NT
HK

Party NameMononuclear Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressShatin NT
HK

Party NameMononuclear Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressShatin NT
HK

Trademark Events


Event DateEvent Description
Monday, December 31, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 11, 2018NEW APPLICATION ENTERED
Wednesday, March 6, 2019ASSIGNED TO EXAMINER
Wednesday, March 13, 2019NON-FINAL ACTION WRITTEN
Wednesday, March 13, 2019NON-FINAL ACTION E-MAILED
Wednesday, March 13, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 12, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, September 14, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 18, 2019ASSIGNED TO LIE
Wednesday, September 25, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 25, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 17, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, June 17, 2020SOU EXTENSION 1 FILED
Wednesday, June 17, 2020USE AMENDMENT FILED
Wednesday, July 1, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 1, 2020SOU EXTENSION 1 GRANTED
Wednesday, October 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 22, 2019PUBLISHED FOR OPPOSITION
Tuesday, October 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 29, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 29, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 17, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, July 1, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 23, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 25, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, December 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 22, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 25, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, December 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED